[Agnogenic myeloid metaplasia and polycythemia vera in the same family]. 1985

F Tosato, and S Pirrone, and M Manzo, and L Diplotti, and E Sponza

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011087 Polycythemia Vera A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs. Erythremia,Osler-Vaquez Disease,Polycythemia Rubra Vera,Polycythemia Ruba Vera,Primary Polycythemia,Disease, Osler-Vaquez,Erythremias,Osler Vaquez Disease,Polycythemia Ruba Veras,Polycythemia Rubra Veras,Polycythemia, Primary,Polycythemias, Primary,Primary Polycythemias,Ruba Vera, Polycythemia,Ruba Veras, Polycythemia,Vera, Polycythemia Ruba,Vera, Polycythemia Rubra,Veras, Polycythemia Ruba,Veras, Polycythemia Rubra
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D055728 Primary Myelofibrosis A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. Agnogenic Myeloid Metaplasia,Bone Marrow Fibrosis,Chronic Idiopathic Myelofibrosis,Fibrosis, Bone Marrow,Idiopathic Myelofibrosis,Myelofibrosis,Myelofibrosis With Myeloid Metaplasia,Myeloid Metaplasia,Myelosclerosis,Myelosis, Nonleukemic,Agnogenic Myeloid Metaplasias,Bone Marrow Fibroses,Fibroses, Bone Marrow,Metaplasia, Agnogenic Myeloid,Metaplasia, Myeloid,Metaplasias, Agnogenic Myeloid,Metaplasias, Myeloid,Myelofibroses,Myelofibroses, Primary,Myelofibrosis, Primary,Myeloid Metaplasia, Agnogenic,Myeloid Metaplasias,Myeloid Metaplasias, Agnogenic,Myeloscleroses,Myeloses, Nonleukemic,Nonleukemic Myeloses,Nonleukemic Myelosis,Primary Myelofibroses

Related Publications

F Tosato, and S Pirrone, and M Manzo, and L Diplotti, and E Sponza
July 1980, The Medical clinics of North America,
F Tosato, and S Pirrone, and M Manzo, and L Diplotti, and E Sponza
October 1973, The New England journal of medicine,
F Tosato, and S Pirrone, and M Manzo, and L Diplotti, and E Sponza
August 2002, International journal of hematology,
F Tosato, and S Pirrone, and M Manzo, and L Diplotti, and E Sponza
January 1997, Medicinski pregled,
F Tosato, and S Pirrone, and M Manzo, and L Diplotti, and E Sponza
September 1952, Revista medica de Costa Rica,
F Tosato, and S Pirrone, and M Manzo, and L Diplotti, and E Sponza
August 1995, Seminars in oncology,
F Tosato, and S Pirrone, and M Manzo, and L Diplotti, and E Sponza
January 1997, Cancer investigation,
F Tosato, and S Pirrone, and M Manzo, and L Diplotti, and E Sponza
May 1959, Radiology,
F Tosato, and S Pirrone, and M Manzo, and L Diplotti, and E Sponza
January 1974, Revista brasileira de pesquisas medicas e biologicas,
Copied contents to your clipboard!